{"count":221304,"next":"https://panelapp-aus.org/api/v1/activities/?format=json&page=1873","previous":"https://panelapp-aus.org/api/v1/activities/?format=json&page=1871","results":[{"created":"2020-04-10T16:03:40.042516+10:00","panel_name":"Mendeliome","panel_id":137,"panel_version":"0.2072","user_name":"Zornitza Stark","item_type":"entity","text":"Classified gene: CR2 as Amber List (moderate evidence)","entity_name":"CR2","entity_type":"gene"},{"created":"2020-04-10T16:03:40.033600+10:00","panel_name":"Mendeliome","panel_id":137,"panel_version":"0.2072","user_name":"Zornitza Stark","item_type":"entity","text":"Gene: cr2 has been classified as Amber List (Moderate Evidence).","entity_name":"CR2","entity_type":"gene"},{"created":"2020-04-10T16:03:19.469288+10:00","panel_name":"Mendeliome","panel_id":137,"panel_version":"0.2071","user_name":"Zornitza Stark","item_type":"entity","text":"reviewed gene: CR2: Rating: AMBER; Mode of pathogenicity: None; Publications: 22035880, 26325596; Phenotypes: Immunodeficiency, common variable, 7, MIM# 614699; Mode of inheritance: BIALLELIC, autosomal or pseudoautosomal","entity_name":"CR2","entity_type":"gene"},{"created":"2020-04-10T16:01:46.307121+10:00","panel_name":"Muscular dystrophy","panel_id":141,"panel_version":"0.6","user_name":"Crystle Lee","item_type":"entity","text":"reviewed gene: DMD: Rating: GREEN; Mode of pathogenicity: None; Publications: ; Phenotypes: Duchenne muscular dystrophy (MIM#310200), Becker muscular dystrophy (MIM#300376); Mode of inheritance: X-LINKED: hemizygous mutation in males, monoallelic mutations in females may cause disease (may be less severe, later onset than males)","entity_name":"DMD","entity_type":"gene"},{"created":"2020-04-10T15:45:58.493443+10:00","panel_name":"Inflammatory bowel disease","panel_id":123,"panel_version":"0.17","user_name":"Zornitza Stark","item_type":"entity","text":"Marked gene: COL7A1 as ready","entity_name":"COL7A1","entity_type":"gene"},{"created":"2020-04-10T15:45:58.483845+10:00","panel_name":"Inflammatory bowel disease","panel_id":123,"panel_version":"0.17","user_name":"Zornitza Stark","item_type":"entity","text":"Gene: col7a1 has been classified as Red List (Low Evidence).","entity_name":"COL7A1","entity_type":"gene"},{"created":"2020-04-10T15:45:46.824992+10:00","panel_name":"Inflammatory bowel disease","panel_id":123,"panel_version":"0.17","user_name":"Zornitza Stark","item_type":"entity","text":"Phenotypes for gene: COL7A1 were changed from  to Epidermolysis bullosa dystrophica, AR, MIM# 226600","entity_name":"COL7A1","entity_type":"gene"},{"created":"2020-04-10T15:44:59.749454+10:00","panel_name":"Inflammatory bowel disease","panel_id":123,"panel_version":"0.16","user_name":"Zornitza Stark","item_type":"entity","text":"Publications for gene: COL7A1 were set to ","entity_name":"COL7A1","entity_type":"gene"},{"created":"2020-04-10T15:44:36.289070+10:00","panel_name":"Inflammatory bowel disease","panel_id":123,"panel_version":"0.15","user_name":"Zornitza Stark","item_type":"entity","text":"Mode of inheritance for gene: COL7A1 was changed from Unknown to BIALLELIC, autosomal or pseudoautosomal","entity_name":"COL7A1","entity_type":"gene"},{"created":"2020-04-10T15:44:12.019898+10:00","panel_name":"Inflammatory bowel disease","panel_id":123,"panel_version":"0.14","user_name":"Zornitza Stark","item_type":"entity","text":"Classified gene: COL7A1 as Red List (low evidence)","entity_name":"COL7A1","entity_type":"gene"},{"created":"2020-04-10T15:44:12.005902+10:00","panel_name":"Inflammatory bowel disease","panel_id":123,"panel_version":"0.14","user_name":"Zornitza Stark","item_type":"entity","text":"Gene: col7a1 has been classified as Red List (Low Evidence).","entity_name":"COL7A1","entity_type":"gene"},{"created":"2020-04-10T15:43:41.699540+10:00","panel_name":"Inflammatory bowel disease","panel_id":123,"panel_version":"0.13","user_name":"Zornitza Stark","item_type":"entity","text":"reviewed gene: COL7A1: Rating: RED; Mode of pathogenicity: None; Publications: 27537055, 25058236; Phenotypes: Epidermolysis bullosa dystrophica, AR, MIM# 226600; Mode of inheritance: BIALLELIC, autosomal or pseudoautosomal","entity_name":"COL7A1","entity_type":"gene"},{"created":"2020-04-10T13:42:25.908452+10:00","panel_name":"Complement Deficiencies","panel_id":224,"panel_version":"0.23","user_name":"Zornitza Stark","item_type":"entity","text":"Marked gene: CFHR5 as ready","entity_name":"CFHR5","entity_type":"gene"},{"created":"2020-04-10T13:42:25.894941+10:00","panel_name":"Complement Deficiencies","panel_id":224,"panel_version":"0.23","user_name":"Zornitza Stark","item_type":"entity","text":"Gene: cfhr5 has been classified as Red List (Low Evidence).","entity_name":"CFHR5","entity_type":"gene"},{"created":"2020-04-10T13:42:22.272212+10:00","panel_name":"Complement Deficiencies","panel_id":224,"panel_version":"0.23","user_name":"Zornitza Stark","item_type":"entity","text":"Phenotypes for gene: CFHR5 were changed from  to Nephropathy due to CFHR5 deficiency, MIM# 614809","entity_name":"CFHR5","entity_type":"gene"},{"created":"2020-04-10T13:41:19.511600+10:00","panel_name":"Complement Deficiencies","panel_id":224,"panel_version":"0.22","user_name":"Zornitza Stark","item_type":"entity","text":"Classified gene: CFHR5 as Red List (low evidence)","entity_name":"CFHR5","entity_type":"gene"},{"created":"2020-04-10T13:41:19.498231+10:00","panel_name":"Complement Deficiencies","panel_id":224,"panel_version":"0.22","user_name":"Zornitza Stark","item_type":"entity","text":"Gene: cfhr5 has been classified as Red List (Low Evidence).","entity_name":"CFHR5","entity_type":"gene"},{"created":"2020-04-10T13:40:48.572409+10:00","panel_name":"Complement Deficiencies","panel_id":224,"panel_version":"0.21","user_name":"Zornitza Stark","item_type":"entity","text":"reviewed gene: CFHR5: Rating: RED; Mode of pathogenicity: None; Publications: ; Phenotypes: Nephropathy due to CFHR5 deficiency, MIM# 614809; Mode of inheritance: MONOALLELIC, autosomal or pseudoautosomal, NOT imprinted","entity_name":"CFHR5","entity_type":"gene"},{"created":"2020-04-10T13:37:37.610089+10:00","panel_name":"Mendeliome","panel_id":137,"panel_version":"0.2071","user_name":"Zornitza Stark","item_type":"entity","text":"Marked gene: CFHR4 as ready","entity_name":"CFHR4","entity_type":"gene"},{"created":"2020-04-10T13:37:37.600853+10:00","panel_name":"Mendeliome","panel_id":137,"panel_version":"0.2071","user_name":"Zornitza Stark","item_type":"entity","text":"Gene: cfhr4 has been classified as Red List (Low Evidence).","entity_name":"CFHR4","entity_type":"gene"},{"created":"2020-04-10T13:37:28.158985+10:00","panel_name":"Mendeliome","panel_id":137,"panel_version":"0.2071","user_name":"Zornitza Stark","item_type":"entity","text":"Classified gene: CFHR4 as Red List (low evidence)","entity_name":"CFHR4","entity_type":"gene"},{"created":"2020-04-10T13:37:28.143209+10:00","panel_name":"Mendeliome","panel_id":137,"panel_version":"0.2071","user_name":"Zornitza Stark","item_type":"entity","text":"Gene: cfhr4 has been classified as Red List (Low Evidence).","entity_name":"CFHR4","entity_type":"gene"},{"created":"2020-04-10T13:37:08.325639+10:00","panel_name":"Mendeliome","panel_id":137,"panel_version":"0.2070","user_name":"Zornitza Stark","item_type":"entity","text":"reviewed gene: CFHR4: Rating: RED; Mode of pathogenicity: None; Publications: ; Phenotypes: ; Mode of inheritance: None","entity_name":"CFHR4","entity_type":"gene"},{"created":"2020-04-10T13:36:42.704247+10:00","panel_name":"Complement Deficiencies","panel_id":224,"panel_version":"0.21","user_name":"Zornitza Stark","item_type":"entity","text":"Marked gene: CFHR4 as ready","entity_name":"CFHR4","entity_type":"gene"},{"created":"2020-04-10T13:36:42.690302+10:00","panel_name":"Complement Deficiencies","panel_id":224,"panel_version":"0.21","user_name":"Zornitza Stark","item_type":"entity","text":"Gene: cfhr4 has been classified as Red List (Low Evidence).","entity_name":"CFHR4","entity_type":"gene"},{"created":"2020-04-10T13:36:34.500852+10:00","panel_name":"Complement Deficiencies","panel_id":224,"panel_version":"0.21","user_name":"Zornitza Stark","item_type":"entity","text":"Classified gene: CFHR4 as Red List (low evidence)","entity_name":"CFHR4","entity_type":"gene"},{"created":"2020-04-10T13:36:34.487347+10:00","panel_name":"Complement Deficiencies","panel_id":224,"panel_version":"0.21","user_name":"Zornitza Stark","item_type":"entity","text":"Gene: cfhr4 has been classified as Red List (Low Evidence).","entity_name":"CFHR4","entity_type":"gene"},{"created":"2020-04-10T13:33:54.722041+10:00","panel_name":"Complement Deficiencies","panel_id":224,"panel_version":"0.20","user_name":"Zornitza Stark","item_type":"entity","text":"changed review comment from: Association is with aHUS, gene is on aHUS panel.; to: No Mendelian gene disease association I can find.","entity_name":"CFHR4","entity_type":"gene"},{"created":"2020-04-10T13:30:52.149336+10:00","panel_name":"Complement Deficiencies","panel_id":224,"panel_version":"0.20","user_name":"Zornitza Stark","item_type":"entity","text":"reviewed gene: CFHR4: Rating: RED; Mode of pathogenicity: None; Publications: ; Phenotypes: Susceptibility to atypical haemolytic uraemic syndrome; Mode of inheritance: None","entity_name":"CFHR4","entity_type":"gene"},{"created":"2020-04-10T13:29:41.329229+10:00","panel_name":"Complement Deficiencies","panel_id":224,"panel_version":"0.20","user_name":"Zornitza Stark","item_type":"entity","text":"Marked gene: CFHR3 as ready","entity_name":"CFHR3","entity_type":"gene"},{"created":"2020-04-10T13:29:41.315238+10:00","panel_name":"Complement Deficiencies","panel_id":224,"panel_version":"0.20","user_name":"Zornitza Stark","item_type":"entity","text":"Gene: cfhr3 has been classified as Red List (Low Evidence).","entity_name":"CFHR3","entity_type":"gene"},{"created":"2020-04-10T13:29:15.646295+10:00","panel_name":"Complement Deficiencies","panel_id":224,"panel_version":"0.20","user_name":"Zornitza Stark","item_type":"entity","text":"Phenotypes for gene: CFHR3 were changed from  to {Hemolytic uremic syndrome, atypical, susceptibility to}, MIM# 235400","entity_name":"CFHR3","entity_type":"gene"},{"created":"2020-04-10T13:28:51.616544+10:00","panel_name":"Complement Deficiencies","panel_id":224,"panel_version":"0.19","user_name":"Zornitza Stark","item_type":"entity","text":"Mode of inheritance for gene: CFHR3 was changed from Unknown to BOTH monoallelic and biallelic, autosomal or pseudoautosomal","entity_name":"CFHR3","entity_type":"gene"},{"created":"2020-04-10T13:28:25.830660+10:00","panel_name":"Complement Deficiencies","panel_id":224,"panel_version":"0.18","user_name":"Zornitza Stark","item_type":"entity","text":"Classified gene: CFHR3 as Red List (low evidence)","entity_name":"CFHR3","entity_type":"gene"},{"created":"2020-04-10T13:28:25.817841+10:00","panel_name":"Complement Deficiencies","panel_id":224,"panel_version":"0.18","user_name":"Zornitza Stark","item_type":"entity","text":"Gene: cfhr3 has been classified as Red List (Low Evidence).","entity_name":"CFHR3","entity_type":"gene"},{"created":"2020-04-10T13:27:52.232806+10:00","panel_name":"Complement Deficiencies","panel_id":224,"panel_version":"0.17","user_name":"Zornitza Stark","item_type":"entity","text":"reviewed gene: CFHR3: Rating: RED; Mode of pathogenicity: None; Publications: ; Phenotypes: {Hemolytic uremic syndrome, atypical, susceptibility to}, MIM# 235400; Mode of inheritance: BOTH monoallelic and biallelic, autosomal or pseudoautosomal","entity_name":"CFHR3","entity_type":"gene"},{"created":"2020-04-10T13:26:15.992583+10:00","panel_name":"Mendeliome","panel_id":137,"panel_version":"0.2070","user_name":"Zornitza Stark","item_type":"entity","text":"Marked gene: CFHR2 as ready","entity_name":"CFHR2","entity_type":"gene"},{"created":"2020-04-10T13:26:15.983004+10:00","panel_name":"Mendeliome","panel_id":137,"panel_version":"0.2070","user_name":"Zornitza Stark","item_type":"entity","text":"Gene: cfhr2 has been classified as Green List (High Evidence).","entity_name":"CFHR2","entity_type":"gene"},{"created":"2020-04-10T13:26:07.466556+10:00","panel_name":"Mendeliome","panel_id":137,"panel_version":"0.2070","user_name":"Zornitza Stark","item_type":"entity","text":"Phenotypes for gene: CFHR2 were changed from  to C3 glomerulopathy; C3G; Immune complex MPGN; IC-MPGN","entity_name":"CFHR2","entity_type":"gene"},{"created":"2020-04-10T13:25:46.631323+10:00","panel_name":"Mendeliome","panel_id":137,"panel_version":"0.2069","user_name":"Zornitza Stark","item_type":"entity","text":"Publications for gene: CFHR2 were set to ","entity_name":"CFHR2","entity_type":"gene"},{"created":"2020-04-10T13:25:22.975845+10:00","panel_name":"Mendeliome","panel_id":137,"panel_version":"0.2068","user_name":"Zornitza Stark","item_type":"entity","text":"Mode of inheritance for gene: CFHR2 was changed from Unknown to BOTH monoallelic and biallelic, autosomal or pseudoautosomal","entity_name":"CFHR2","entity_type":"gene"},{"created":"2020-04-10T13:25:07.883587+10:00","panel_name":"Mendeliome","panel_id":137,"panel_version":"0.2067","user_name":"Zornitza Stark","item_type":"entity","text":"Tag SV/CNV tag was added to gene: CFHR2.","entity_name":"CFHR2","entity_type":"gene"},{"created":"2020-04-10T13:24:53.423882+10:00","panel_name":"Mendeliome","panel_id":137,"panel_version":"0.2067","user_name":"Zornitza Stark","item_type":"entity","text":"reviewed gene: CFHR2: Rating: GREEN; Mode of pathogenicity: None; Publications: 24334459, 23728178, 20800271; Phenotypes: C3 glomerulopathy, C3G, Immune complex MPGN, IC-MPGN; Mode of inheritance: BOTH monoallelic and biallelic, autosomal or pseudoautosomal","entity_name":"CFHR2","entity_type":"gene"},{"created":"2020-04-10T13:23:08.263718+10:00","panel_name":"Complement Deficiencies","panel_id":224,"panel_version":"0.17","user_name":"Zornitza Stark","item_type":"entity","text":"Tag SV/CNV tag was added to gene: CFHR2.","entity_name":"CFHR2","entity_type":"gene"},{"created":"2020-04-10T13:22:23.743840+10:00","panel_name":"Complement Deficiencies","panel_id":224,"panel_version":"0.17","user_name":"Zornitza Stark","item_type":"entity","text":"Marked gene: CFHR2 as ready","entity_name":"CFHR2","entity_type":"gene"},{"created":"2020-04-10T13:22:23.729620+10:00","panel_name":"Complement Deficiencies","panel_id":224,"panel_version":"0.17","user_name":"Zornitza Stark","item_type":"entity","text":"Gene: cfhr2 has been classified as Red List (Low Evidence).","entity_name":"CFHR2","entity_type":"gene"},{"created":"2020-04-10T13:22:18.819525+10:00","panel_name":"Complement Deficiencies","panel_id":224,"panel_version":"0.17","user_name":"Zornitza Stark","item_type":"entity","text":"Phenotypes for gene: CFHR2 were changed from  to C3 glomerulopathy; C3G; Immune complex MPGN; IC-MPGN","entity_name":"CFHR2","entity_type":"gene"},{"created":"2020-04-10T13:21:55.239508+10:00","panel_name":"Complement Deficiencies","panel_id":224,"panel_version":"0.16","user_name":"Zornitza Stark","item_type":"entity","text":"Publications for gene: CFHR2 were set to ","entity_name":"CFHR2","entity_type":"gene"},{"created":"2020-04-10T13:21:32.185752+10:00","panel_name":"Complement Deficiencies","panel_id":224,"panel_version":"0.15","user_name":"Zornitza Stark","item_type":"entity","text":"Mode of inheritance for gene: CFHR2 was changed from Unknown to BOTH monoallelic and biallelic, autosomal or pseudoautosomal","entity_name":"CFHR2","entity_type":"gene"},{"created":"2020-04-10T13:21:03.715255+10:00","panel_name":"Complement Deficiencies","panel_id":224,"panel_version":"0.14","user_name":"Zornitza Stark","item_type":"entity","text":"Classified gene: CFHR2 as Red List (low evidence)","entity_name":"CFHR2","entity_type":"gene"},{"created":"2020-04-10T13:21:03.706414+10:00","panel_name":"Complement Deficiencies","panel_id":224,"panel_version":"0.14","user_name":"Zornitza Stark","item_type":"entity","text":"Gene: cfhr2 has been classified as Red List (Low Evidence).","entity_name":"CFHR2","entity_type":"gene"},{"created":"2020-04-10T13:20:33.071372+10:00","panel_name":"Complement Deficiencies","panel_id":224,"panel_version":"0.13","user_name":"Zornitza Stark","item_type":"entity","text":"reviewed gene: CFHR2: Rating: RED; Mode of pathogenicity: None; Publications: 24334459, 23728178, 20800271; Phenotypes: C3 glomerulopathy, C3G, Immune complex MPGN, IC-MPGN; Mode of inheritance: BOTH monoallelic and biallelic, autosomal or pseudoautosomal","entity_name":"CFHR2","entity_type":"gene"},{"created":"2020-04-10T13:17:02.221756+10:00","panel_name":"Complement Deficiencies","panel_id":224,"panel_version":"0.13","user_name":"Zornitza Stark","item_type":"entity","text":"Marked gene: CFHR1 as ready","entity_name":"CFHR1","entity_type":"gene"},{"created":"2020-04-10T13:17:02.198936+10:00","panel_name":"Complement Deficiencies","panel_id":224,"panel_version":"0.13","user_name":"Zornitza Stark","item_type":"entity","text":"Gene: cfhr1 has been classified as Red List (Low Evidence).","entity_name":"CFHR1","entity_type":"gene"},{"created":"2020-04-10T13:16:58.004538+10:00","panel_name":"Complement Deficiencies","panel_id":224,"panel_version":"0.13","user_name":"Zornitza Stark","item_type":"entity","text":"Classified gene: CFHR1 as Red List (low evidence)","entity_name":"CFHR1","entity_type":"gene"},{"created":"2020-04-10T13:16:57.990547+10:00","panel_name":"Complement Deficiencies","panel_id":224,"panel_version":"0.13","user_name":"Zornitza Stark","item_type":"entity","text":"Gene: cfhr1 has been classified as Red List (Low Evidence).","entity_name":"CFHR1","entity_type":"gene"},{"created":"2020-04-10T13:16:27.365202+10:00","panel_name":"Complement Deficiencies","panel_id":224,"panel_version":"0.12","user_name":"Zornitza Stark","item_type":"entity","text":"reviewed gene: CFHR1: Rating: RED; Mode of pathogenicity: None; Publications: ; Phenotypes: ; Mode of inheritance: None","entity_name":"CFHR1","entity_type":"gene"},{"created":"2020-04-10T13:12:03.415084+10:00","panel_name":"Mendeliome","panel_id":137,"panel_version":"0.2067","user_name":"Zornitza Stark","item_type":"entity","text":"Phenotypes for gene: CFB were changed from Complement factor B deficiency, MIM# 615561 to Complement factor B deficiency, MIM# 615561; {Hemolytic uremic syndrome, atypical, susceptibility to, 4} 612924","entity_name":"CFB","entity_type":"gene"},{"created":"2020-04-10T13:11:38.496034+10:00","panel_name":"Mendeliome","panel_id":137,"panel_version":"0.2066","user_name":"Zornitza Stark","item_type":"entity","text":"Publications for gene: CFB were set to 24152280","entity_name":"CFB","entity_type":"gene"},{"created":"2020-04-10T13:11:00.229893+10:00","panel_name":"Mendeliome","panel_id":137,"panel_version":"0.2065","user_name":"Zornitza Stark","item_type":"entity","text":"Mode of inheritance for gene: CFB was changed from BIALLELIC, autosomal or pseudoautosomal to BOTH monoallelic and biallelic, autosomal or pseudoautosomal","entity_name":"CFB","entity_type":"gene"},{"created":"2020-04-10T13:10:40.892826+10:00","panel_name":"Mendeliome","panel_id":137,"panel_version":"0.2064","user_name":"Zornitza Stark","item_type":"entity","text":"Classified gene: CFB as Green List (high evidence)","entity_name":"CFB","entity_type":"gene"},{"created":"2020-04-10T13:10:40.883699+10:00","panel_name":"Mendeliome","panel_id":137,"panel_version":"0.2064","user_name":"Zornitza Stark","item_type":"entity","text":"Gene: cfb has been classified as Green List (High Evidence).","entity_name":"CFB","entity_type":"gene"},{"created":"2020-04-10T13:10:20.679575+10:00","panel_name":"Mendeliome","panel_id":137,"panel_version":"0.2063","user_name":"Zornitza Stark","item_type":"entity","text":"changed review comment from: Single individual reported, supportive immunophenotyping data.; to: Single individual reported with bi-allelic variants and complement deficiency, supportive immunophenotyping data. Mono-allelic variants linked to susceptibility to aHUS.","entity_name":"CFB","entity_type":"gene"},{"created":"2020-04-10T13:09:41.680837+10:00","panel_name":"Mendeliome","panel_id":137,"panel_version":"0.2063","user_name":"Zornitza Stark","item_type":"entity","text":"edited their review of gene: CFB: Changed rating: GREEN; Changed publications: 24152280, 17182750; Changed phenotypes: Complement factor B deficiency, MIM# 615561, {Hemolytic uremic syndrome, atypical, susceptibility to, 4} 612924; Changed mode of inheritance: BOTH monoallelic and biallelic, autosomal or pseudoautosomal","entity_name":"CFB","entity_type":"gene"},{"created":"2020-04-10T13:07:40.043099+10:00","panel_name":"Mendeliome","panel_id":137,"panel_version":"0.2063","user_name":"Zornitza Stark","item_type":"entity","text":"Marked gene: CFB as ready","entity_name":"CFB","entity_type":"gene"},{"created":"2020-04-10T13:07:40.033839+10:00","panel_name":"Mendeliome","panel_id":137,"panel_version":"0.2063","user_name":"Zornitza Stark","item_type":"entity","text":"Gene: cfb has been classified as Amber List (Moderate Evidence).","entity_name":"CFB","entity_type":"gene"},{"created":"2020-04-10T13:07:29.480842+10:00","panel_name":"Mendeliome","panel_id":137,"panel_version":"0.2063","user_name":"Zornitza Stark","item_type":"entity","text":"Phenotypes for gene: CFB were changed from  to Complement factor B deficiency, MIM# 615561","entity_name":"CFB","entity_type":"gene"},{"created":"2020-04-10T13:07:14.236841+10:00","panel_name":"Mendeliome","panel_id":137,"panel_version":"0.2062","user_name":"Zornitza Stark","item_type":"entity","text":"Publications for gene: CFB were set to ","entity_name":"CFB","entity_type":"gene"},{"created":"2020-04-10T13:07:00.666571+10:00","panel_name":"Mendeliome","panel_id":137,"panel_version":"0.2061","user_name":"Zornitza Stark","item_type":"entity","text":"Mode of inheritance for gene: CFB was changed from Unknown to BIALLELIC, autosomal or pseudoautosomal","entity_name":"CFB","entity_type":"gene"},{"created":"2020-04-10T13:06:45.589638+10:00","panel_name":"Mendeliome","panel_id":137,"panel_version":"0.2060","user_name":"Zornitza Stark","item_type":"entity","text":"Classified gene: CFB as Amber List (moderate evidence)","entity_name":"CFB","entity_type":"gene"},{"created":"2020-04-10T13:06:45.579173+10:00","panel_name":"Mendeliome","panel_id":137,"panel_version":"0.2060","user_name":"Zornitza Stark","item_type":"entity","text":"Gene: cfb has been classified as Amber List (Moderate Evidence).","entity_name":"CFB","entity_type":"gene"},{"created":"2020-04-10T13:06:26.540810+10:00","panel_name":"Mendeliome","panel_id":137,"panel_version":"0.2059","user_name":"Zornitza Stark","item_type":"entity","text":"reviewed gene: CFB: Rating: AMBER; Mode of pathogenicity: None; Publications: 24152280; Phenotypes: Complement factor B deficiency, MIM# 615561; Mode of inheritance: BIALLELIC, autosomal or pseudoautosomal","entity_name":"CFB","entity_type":"gene"},{"created":"2020-04-10T13:06:18.955740+10:00","panel_name":"Complement Deficiencies","panel_id":224,"panel_version":"0.12","user_name":"Zornitza Stark","item_type":"entity","text":"Phenotypes for gene: CFB were changed from  to Complement factor B deficiency, MIM# 615561","entity_name":"CFB","entity_type":"gene"},{"created":"2020-04-10T13:01:43.881203+10:00","panel_name":"Complement Deficiencies","panel_id":224,"panel_version":"0.11","user_name":"Zornitza Stark","item_type":"entity","text":"Publications for gene: CFB were set to ","entity_name":"CFB","entity_type":"gene"},{"created":"2020-04-10T13:01:20.767592+10:00","panel_name":"Complement Deficiencies","panel_id":224,"panel_version":"0.10","user_name":"Zornitza Stark","item_type":"entity","text":"Mode of inheritance for gene: CFB was changed from Unknown to BIALLELIC, autosomal or pseudoautosomal","entity_name":"CFB","entity_type":"gene"},{"created":"2020-04-10T13:00:56.444254+10:00","panel_name":"Complement Deficiencies","panel_id":224,"panel_version":"0.9","user_name":"Zornitza Stark","item_type":"entity","text":"Classified gene: CFB as Amber List (moderate evidence)","entity_name":"CFB","entity_type":"gene"},{"created":"2020-04-10T13:00:56.435771+10:00","panel_name":"Complement Deficiencies","panel_id":224,"panel_version":"0.9","user_name":"Zornitza Stark","item_type":"entity","text":"Gene: cfb has been classified as Amber List (Moderate Evidence).","entity_name":"CFB","entity_type":"gene"},{"created":"2020-04-10T13:00:26.549234+10:00","panel_name":"Complement Deficiencies","panel_id":224,"panel_version":"0.8","user_name":"Zornitza Stark","item_type":"entity","text":"reviewed gene: CFB: Rating: AMBER; Mode of pathogenicity: None; Publications: 24152280; Phenotypes: Complement factor B deficiency, MIM# 615561; Mode of inheritance: BIALLELIC, autosomal or pseudoautosomal","entity_name":"CFB","entity_type":"gene"},{"created":"2020-04-10T12:57:02.695306+10:00","panel_name":"Combined Immunodeficiency","panel_id":223,"panel_version":"0.109","user_name":"Zornitza Stark","item_type":"entity","text":"Marked gene: CD8A as ready","entity_name":"CD8A","entity_type":"gene"},{"created":"2020-04-10T12:57:02.681995+10:00","panel_name":"Combined Immunodeficiency","panel_id":223,"panel_version":"0.109","user_name":"Zornitza Stark","item_type":"entity","text":"Gene: cd8a has been classified as Amber List (Moderate Evidence).","entity_name":"CD8A","entity_type":"gene"},{"created":"2020-04-10T12:56:20.402709+10:00","panel_name":"Mendeliome","panel_id":137,"panel_version":"0.2059","user_name":"Zornitza Stark","item_type":"entity","text":"Marked gene: CD8A as ready","entity_name":"CD8A","entity_type":"gene"},{"created":"2020-04-10T12:56:20.388727+10:00","panel_name":"Mendeliome","panel_id":137,"panel_version":"0.2059","user_name":"Zornitza Stark","item_type":"entity","text":"Gene: cd8a has been classified as Amber List (Moderate Evidence).","entity_name":"CD8A","entity_type":"gene"},{"created":"2020-04-10T12:55:56.181959+10:00","panel_name":"Mendeliome","panel_id":137,"panel_version":"0.2059","user_name":"Zornitza Stark","item_type":"entity","text":"Phenotypes for gene: CD8A were changed from  to CD8 deficiency, familial, MIM# 608957","entity_name":"CD8A","entity_type":"gene"},{"created":"2020-04-10T12:55:45.796060+10:00","panel_name":"Combined Immunodeficiency","panel_id":223,"panel_version":"0.109","user_name":"Zornitza Stark","item_type":"entity","text":"Publications for gene: CD8A were set to ","entity_name":"CD8A","entity_type":"gene"},{"created":"2020-04-10T12:55:43.188166+10:00","panel_name":"Mendeliome","panel_id":137,"panel_version":"0.2058","user_name":"Zornitza Stark","item_type":"entity","text":"Publications for gene: CD8A were set to ","entity_name":"CD8A","entity_type":"gene"},{"created":"2020-04-10T12:55:19.479812+10:00","panel_name":"Mendeliome","panel_id":137,"panel_version":"0.2057","user_name":"Zornitza Stark","item_type":"entity","text":"Mode of inheritance for gene: CD8A was changed from Unknown to BIALLELIC, autosomal or pseudoautosomal","entity_name":"CD8A","entity_type":"gene"},{"created":"2020-04-10T12:54:45.135473+10:00","panel_name":"Mendeliome","panel_id":137,"panel_version":"0.2056","user_name":"Zornitza Stark","item_type":"entity","text":"Classified gene: CD8A as Amber List (moderate evidence)","entity_name":"CD8A","entity_type":"gene"},{"created":"2020-04-10T12:54:45.126745+10:00","panel_name":"Mendeliome","panel_id":137,"panel_version":"0.2056","user_name":"Zornitza Stark","item_type":"entity","text":"Gene: cd8a has been classified as Amber List (Moderate Evidence).","entity_name":"CD8A","entity_type":"gene"},{"created":"2020-04-10T12:54:26.052915+10:00","panel_name":"Combined Immunodeficiency","panel_id":223,"panel_version":"0.108","user_name":"Zornitza Stark","item_type":"entity","text":"Phenotypes for gene: CD8A were changed from  to CD8 deficiency, familial, MIM# 608957","entity_name":"CD8A","entity_type":"gene"},{"created":"2020-04-10T12:54:24.121934+10:00","panel_name":"Mendeliome","panel_id":137,"panel_version":"0.2055","user_name":"Zornitza Stark","item_type":"entity","text":"reviewed gene: CD8A: Rating: AMBER; Mode of pathogenicity: None; Publications: 11435463, 17658607, 26563160; Phenotypes: CD8 deficiency, familial, MIM# 608957; Mode of inheritance: BIALLELIC, autosomal or pseudoautosomal","entity_name":"CD8A","entity_type":"gene"},{"created":"2020-04-10T12:54:01.864218+10:00","panel_name":"Combined Immunodeficiency","panel_id":223,"panel_version":"0.107","user_name":"Zornitza Stark","item_type":"entity","text":"Mode of inheritance for gene: CD8A was changed from Unknown to BIALLELIC, autosomal or pseudoautosomal","entity_name":"CD8A","entity_type":"gene"},{"created":"2020-04-10T12:51:40.468404+10:00","panel_name":"Combined Immunodeficiency","panel_id":223,"panel_version":"0.106","user_name":"Zornitza Stark","item_type":"entity","text":"Classified gene: CD8A as Amber List (moderate evidence)","entity_name":"CD8A","entity_type":"gene"},{"created":"2020-04-10T12:51:40.459632+10:00","panel_name":"Combined Immunodeficiency","panel_id":223,"panel_version":"0.106","user_name":"Zornitza Stark","item_type":"entity","text":"Gene: cd8a has been classified as Amber List (Moderate Evidence).","entity_name":"CD8A","entity_type":"gene"},{"created":"2020-04-10T12:50:49.451893+10:00","panel_name":"Combined Immunodeficiency","panel_id":223,"panel_version":"0.105","user_name":"Zornitza Stark","item_type":"entity","text":"edited their review of gene: CD8A: Changed rating: AMBER","entity_name":"CD8A","entity_type":"gene"},{"created":"2020-04-10T12:50:41.787075+10:00","panel_name":"Combined Immunodeficiency","panel_id":223,"panel_version":"0.105","user_name":"Zornitza Stark","item_type":"entity","text":"reviewed gene: CD8A: Rating: ; Mode of pathogenicity: None; Publications: 11435463, 17658607, 26563160; Phenotypes: CD8 deficiency, familial, MIM# 608957; Mode of inheritance: BIALLELIC, autosomal or pseudoautosomal","entity_name":"CD8A","entity_type":"gene"},{"created":"2020-04-10T12:32:43.860017+10:00","panel_name":"Mendeliome","panel_id":137,"panel_version":"0.2055","user_name":"Zornitza Stark","item_type":"entity","text":"Marked gene: CD81 as ready","entity_name":"CD81","entity_type":"gene"},{"created":"2020-04-10T12:32:43.846366+10:00","panel_name":"Mendeliome","panel_id":137,"panel_version":"0.2055","user_name":"Zornitza Stark","item_type":"entity","text":"Gene: cd81 has been classified as Amber List (Moderate Evidence).","entity_name":"CD81","entity_type":"gene"},{"created":"2020-04-10T12:32:32.753697+10:00","panel_name":"Mendeliome","panel_id":137,"panel_version":"0.2055","user_name":"Zornitza Stark","item_type":"entity","text":"Phenotypes for gene: CD81 were changed from  to Immunodeficiency, common variable, 6, MIM# 613496","entity_name":"CD81","entity_type":"gene"},{"created":"2020-04-10T12:32:12.582143+10:00","panel_name":"Mendeliome","panel_id":137,"panel_version":"0.2054","user_name":"Zornitza Stark","item_type":"entity","text":"Publications for gene: CD81 were set to ","entity_name":"CD81","entity_type":"gene"},{"created":"2020-04-10T12:31:50.583337+10:00","panel_name":"Mendeliome","panel_id":137,"panel_version":"0.2053","user_name":"Zornitza Stark","item_type":"entity","text":"Mode of inheritance for gene: CD81 was changed from Unknown to BIALLELIC, autosomal or pseudoautosomal","entity_name":"CD81","entity_type":"gene"}]}